XK
ONC

Xact Kapitalforvaltning’s BeOne Medicines Ltd ONC Stock Holding History

Xact Kapitalforvaltning’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.48M Buy
12,000
+900
+8% +$141K 0.03% 403
2019
Q4 		$1.84M Buy
+11,100
New +$1.84M 0.03% 431
2019
Q2 		– Sell
-3,900
Closed -$515K – 1476
2019
Q1 		$515K Buy
+3,900
New +$526K 0.01% 901

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Xact Kapitalforvaltning's ONC Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its BeOne Medicines Ltd (ONC) stake by 8.1% in Q1 2020, buying an estimated $141K and bringing the position to 12,000 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #403.

Xact Kapitalforvaltning first reported a position in ONC in Q1 2019 and has held it in 3 quarters since. The position peaked at $1.84M in Q4 2019. 215 funds tracked by Wall St. Rank hold ONC as of Q1 2020.

  • Xact Kapitalforvaltning held 12,000 shares of BeOne Medicines Ltd worth $1.48M as of Q1 2020.
  • Xact Kapitalforvaltning bought 900 BeOne Medicines Ltd shares in Q1 2020, an estimated $141K.
  • BeOne Medicines Ltd made up 0.03% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #403 holding.
  • Xact Kapitalforvaltning first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 3 quarters since.
  • Xact Kapitalforvaltning's BeOne Medicines Ltd position peaked at $1.84M in Q4 2019.
  • 215 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.